Viewing nowLyrica Capsules 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Withus Pharma Co., Ltd.

MFDS item code 201603419 · Approved 2016.06.14 · Insurance code 660702960
Treatment of neuropathic pain, adjunctive treatment of partial-onset seizures, and treatment of fibromyalgia
This medication is used to treat peripheral and central neuropathic pain in adults and is utilized as an adjunct for partial seizures in patients with epilepsy. It is also effective in alleviating symptoms of fibromyalgia. Through these effects, it helps relieve pain and manage seizures. Overall, it is used for the treatment of nerve-related pain and seizures.
Administer the total daily dose of pregabalin orally in 2 divided doses, with or without food. Since this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function (see section '5. Patients with renal impairment'). 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The initial dose of this medicine may be 150 mg daily. Depending on each patient's response and tolerability, the dose may be increased to 300 mg daily after 3 to 7 days. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg daily. 2) Central neuropathic pain Adults: The initial dose of this medicine may be 150 mg daily. Depending on each patient's response and tolerability, the dose may be increased to 300 mg daily after 1 week. After an additional week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered (see section '4. Discontinuation of treatment'). 2. Epilepsy Adults: The initial dose of this medicine may be 150 mg daily. Depending on each patient's response and tolerability, the dose may be increased to 300 mg daily after 1 week. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg daily. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg daily. The initial dose is 75 mg twice daily (150 mg daily); depending on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg daily). For patients who do not experience sufficient benefit at 300 mg daily, the dose may be increased within 1 week to 225 mg twice daily (450 mg daily). Clinical studies have also been conducted at a dose of 600 mg daily, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg daily are not recommended. 4. Discontinuation of treatment Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is primarily excreted unchanged by the kidneys. Since its clearance is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. *: For women, multiply the result obtained from the above calculation by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, an immediate supplemental dose should be administered after each 4-hour hemodialysis session. [Table 1]. Pregabalin dose based on renal function Creatinine clearance (CLcr), (mL/min) Total daily dose of pregabalin a Dosing regimen Starting dose (mg/day) Maximum dose (mg/day) ≥60: 150, 600, BID or TID ≥30 -<60: 75, 300, BID or TID ≥15 -<30: 25-50, 150, QD or BID <15: 25, 75, QD Supplemental dose after hemodialysis: 25, 100, single dose b TID = total daily dose divided into 3 doses BID = total daily dose divided into 2 doses QD = once daily a: The total daily dose (mg/day) should be divided as specified in the dosing regimen. b: Supplemental dose refers to an additional single dose. 6. Patients with hepatic impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Older adults (aged 65 years and older) Dose reduction may be necessary in older adults with impaired renal function.
Children under 12 years of age: Use is not recommended because there are insufficient safety and efficacy data. Adolescent patients aged 12 ~17 years: Use is not recommended because there are insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behaviors, so if mood changes or depressive symptoms occur during treatment, consult a healthcare professional immediately. Do not take this medication if you are allergic to any of its components, and it should not be given to patients with certain genetic problems, such as lactose intolerance. For diabetic patients, weight gain may affect blood sugar control, so dosage adjustments for hypoglycemic agents may be necessary. If allergic reactions such as angioedema occur, discontinue the medication immediately and inform a healthcare professional. Elderly patients should be cautious as dizziness or drowsiness may increase the risk of falls or accidents, especially at the beginning of treatment. Consult a healthcare professional if you experience blurred vision or changes in eyesight. Sudden discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headache, and anxiety; therefore, dosage should be gradually reduced according to a healthcare professional's instructions. Patients with a history of substance abuse should be particularly cautious as there is a higher potential for misuse and dependence on this medication. Patients with impaired renal function may require dosage adjustments, and those with heart conditions should be carefully evaluated before use. Taking this medication with opioid analgesics can increase central nervous system depressant effects, raising the risk of respiratory depression. In early pregnancy, the risk of congenital defects in the fetus may be present, so pregnant women should avoid this medication, and women of childbearing age should use effective contraception. During breastfeeding, this medication can be passed into breast milk, and its safety for infants has not been established, so consideration should be given to discontinuing breastfeeding or the medication. Be cautious while performing hazardous activities like driving or operating machinery, as dizziness or drowsiness may occur due to this medication. In case of overdose, confusion, drowsiness, depression, seizures, etc., may occur; immediate emergency treatment is necessary, and blood dialysis may be performed if needed. Store in a safe place out of reach of children, and do not transfer the medication to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. Additionally, it is recommended to store the medication at a temperature between 15 degrees and 30 degrees, avoiding extremes of heat or cold.
A hard capsule with a white or pale yellow powder inside, with the upper and lower parts being white.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Withus Pharma Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.